Multimorbidity in type 1 Gaucher disease patients under miglustat therapy

被引：0

作者：

Engay, Blanca Medrano ^{[1
]}

Roy, Ana ^{[2
]}

Atutxa, Koldo ^{[3
]}

Diaz-Morant, Vicente ^{[4
]}

Garcia-Frade, Javier ^{[5
]}

Hernandez-Martin, Roberto ^{[6
]}

Luno, Elisa ^{[7
]}

Noya, Soledad ^{[8
]}

de la Serna, Javier ^{[9
]}

Villalon, Lucia ^{[10
]}

Giraldo, Pilar ^{[11
]}

机构：

[1] Inst Invest Sanitaria Aragon, Zaragoza, Spain

[2] Fdn Espanola Estudio & Terapeut Enfermedad Gauche, Zaragoza, Spain

[3] Hosp Galdakao, Bilbao, Spain

[4] Hosp Serrania Ronda, Ronda, Spain

[5] Hosp Rio Hortega, Valladolid, Spain

[6] Hosp Virgen de la Concha, Zamora, Spain

[7] Hosp Univ Cent Asturias, Oviedo, Spain

[8] Hosp Teresa Herrera, La Coruna, Spain

[9] Hosp Univ Doce Octubre, Madrid, Spain

[10] Hosp Alcorcon, Madrid, Spain

[11] Ciber Enfermedades Raras, Zaragoza, Spain

来源：

MOLECULAR GENETICS AND METABOLISM | 2018年 / 123卷 / 02期

关键词：

D O I：

10.1016/j.ymgme.2017.12.245

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

236

引用

页码：S93 / S94

页数：2

共 50 条

[11] Substrate reduction therapy with miglustat for type 1 Gaucher disease: A retrospective analysis from a single institution
Machaczka, Maciej
Hast, Robert
Dahlman, Ingrid
Lerner, Richard
Klimkowska, Monika
Engvall, Martin
Hagglund, Hans
UPSALA JOURNAL OF MEDICAL SCIENCES, 2012, 117 (01) : 28 - 34
[12] LONG TERM EFFICACY AND SAFETY OF MIGLUSTAT THERAPY IN TYPE 1 GAUCHER DISEASE. ZAGAL STUDY
Giraldo, P.
Latre, P.
Acedo, A.
Alonso, D.
Barez, A.
Martin, A.
Franco, R.
Fernandez-Villamot, A.
Pocovi, M.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 423 - 423
[13] Oral maintenance with miglustat in adult patients with type 1 Gaucher disease: The patients quality-of-life perspective
Elstein, D.
Dweck, A.
Attias, D.
Hadas-Halpern, I
Zevin, S.
Altarescu, G.
Zimran, A.
JOURNAL OF INHERITED METABOLIC DISEASE, 2007, 30 : 120 - 120
[14] Switching from imiglucerase to miglustat for the treatment of French patients with Gaucher disease type 1: A case series
Serratrice C.
Swiader L.
Serratrice J.
Journal of Medical Case Reports, 9 (1)
[15] ADULT PATIENTS WITH TYPE I GAUCHER DISEASE (GD 1) ON LONG-TERM MIGLUSTAT TREATMENT
Hollak, C.
Heitner, R.
Hrebicek, M.
Elstein, D.
Zimran, A.
JOURNAL OF INHERITED METABOLIC DISEASE, 2005, 28 : 171 - 171
[16] Treatment by miglustat of a young adult presenting type 1 Gaucher's disease
Djerad, Hama
PRESSE MEDICALE, 2006, 35 : S33 - S34
[17] Deficiency of intestinal disaccharidases and miglustat in Gaucher disease patients
Medrano Engay, Blanca
Irun Irun, Pilar
Andrade Campos, Marcio Miguel
Pocovi Mieras, Miguel
Giraldo, Pilar
MOLECULAR GENETICS AND METABOLISM, 2016, 117 (02) : S79 - S79
[18] A TREATMENT EXPERIENCE OF TYPE 3 GAUCHER DISEASE: PIRACETAM AND MIGLUSTAT THERAPY IN PROGRESSIVE MYOCLONIC EPILEPSY
Onal, H.
Adal, E.
Ersen, A.
Aydin, A.
JOURNAL OF INHERITED METABOLIC DISEASE, 2010, 33 : S151 - S151
[19] Post-marketing surveillance of miglustat in type 1 Gaucher disease (GD1)
Hughes, D. A.
Hollak, C. E. M.
Schwierin, B.
Bembi, B.
JOURNAL OF INHERITED METABOLIC DISEASE, 2007, 30 : 119 - 119
[20] Successful switch from enzyme replacement therapy to miglustat in an adult patient with type 1 Gaucher disease: a case report
Giuffrida G.
Lombardo R.
Di Francesco E.
Parrinello L.
Di Raimondo F.
Fiumara A.
Journal of Medical Case Reports, 10 (1) : 1 - 6

← 1 2 3 4 5 →